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Abstract 1 
Salmonella Infantis (SI) became endemic in Hungary where the PFGE cluster B, 2 
characterized by a large multiresistance (MDR) plasmid emerged among broilers leading to 3 
an increased occurrence in humans. We hypothesised that this plasmid (pSI54/04) assisted 4 
dissemination of SI. Indeed, Nal-Sul-Tet phenotypes carrying pSI54/04 occurred increasingly 5 
between 2011-2013 among SI isolates from broilers and humans. Characterization of 6 
pSI54/04 based on genome sequence data of the MDR strain SI54/04 indicated a size of ~277 7 
kb and a high sequence similarity with the megaplasmid pESI of SI predominant in Israel. 8 
Molecular characterization of 78 representative broiler and human isolates detected the 9 
prototype plasmid pSI54/04 and its variants of together with novel plasmid associations 10 
within the emerging cluster B. To test in vitro and in vivo pathogenicity of pSI54/04 we 11 
produced plasmidic transconjugant of the plasmid-free pre-emergent strain SI69/94. This 12 
parental strain and its transconjugant have been tested on chicken embryo fibroblasts (CEFs) 13 
and in orally infected day old chicks. The uptake of pSI54/04 did not increase the 14 
pathogenicity of the strain SI69/94 in these systems. Thus, dissemination of SI in poultry 15 
could be assisted by antimicrobial resistance rather than by virulence modules of the endemic 16 
plasmid pSI54/04 in Hungary. 17 
Keywords: S. Infantis; plasmid; broilers; PFGE clone; molecular typing 18 
1. Introduction 19 
Salmonella Infantis has been the most prevalent serovar isolated from fresh poultry 20 
meat and broiler flocks all over in Europe (EFSA and ECDC, 2015) and in several other 21 
countries like Israel in 2007-2009 (Gal-Mor et al., 2010) and Japan 2000-2003 (Asai et al., 22 
2006; Shahada et al., 2006). Concomitantly S. Infantis became the fourth most widespread 23 
serovar isolated from humans in the EU, behind S. Enteritidis, S. Typhimurium and 24 
monophasic S. Typhimurium 1,4,[5],12:i:- (EFSA and ECDC, 2015). Earlier S. Infantis has 25 
been frequently isolated from asymptomatic poultry (Asai et al., 2006; Shahada et al., 2006), 26 
and human patients in Japan (Murakami et al., 2007). It became the most dominant serovar in 27 
poultry and in the human population in Israel (Gal-Mor et al 2010). 28 
Dissemination of multidrug resistant (MDR) S. Infantis in Belgian poultry carrying a 29 
blaTEM-52 plasmid has been reported by Cloeckaert et al. (2007). The first evidence for clonal 30 
spread of S. Infantis strains in broiler and in human populations with a large conjugative 31 
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MDR plasmid (>168 kb) carrying a class 1 integron (containing the aadA1 gene cassette for 32 
streptomycin/spectinomycin resistance) and the tet(A) gene for tetracycline resistance came 33 
from Hungary (Nógrády et al., 2007). Emerging strains characteristically showing nalidixic 34 
acid-streptomycin-sulphonamide-tetracycline (NalStrSulTet) resistance belong to the 35 
dominant PFGE cluster B (Nógrády et al., 2007; 2008). The representative strain SI54/04 of 36 
this cluster B has been sequenced and its large MDR plasmid, earlier estimated as >168 kb, 37 
has been determined as ~277 kb (Olasz et al., 2015). Our further studies have shown that 38 
these MDR S. Infantis strains are also endemic among broilers in several European countries, 39 
especially in Austria and Poland and belong to the same or closely related clones as the 40 
Hungarian cluster B (Nógrády et al., 2012). Furthermore, they also carry the same or very 41 
similar large MDR plasmid with class 1 integron and tet(A) gene. 42 
Here we aimed at studying the recent epidemiology of MDR S. Infantis in Hungary by 43 
molecular characterization of the strains and of the emerging ~277 kb MDR plasmid 44 
designated as pSI54/04. Plasmid pSI54/04 of the emerging Hungarian broiler strain SI54/04 45 
revealed high sequence similarity with the megaplasmid pESI of a human S. Infantis strain 46 
(Aviv et al., 2014) concerning its specific regions with functions in antimicrobial resistance, 47 
virulence, plasmid maintenance and transfer. Molecular typing of recent S. Infantis strains of 48 
broiler and human origin indicated that the PFGE cluster B carrying this MDR plasmid is still 49 
endemic and pSI54/04 might have contributed to the unprecedented spread of S. Infantis 50 
between 2000-2013 in the Hungarian broiler flocks and to a much lesser degree in humans. 51 
2. Materials and methods 52 
2.1. Strains of Salmonella Infantis and antimicrobial resistance phenotyping 53 
A collection of 186 epidemiologically unrelated strains of S. Infantis was established, 54 
by choosing isolates with differing geographic origin, covering as much of Hungary as 55 
possible for the years of 2011-2013, containing approximately equal numbers of broiler and 56 
human isolates without causative links between them (Table S1). This basic collection was set 57 
up in order to represent the antimicrobial resistance profiles of S. Infantis in Hungarian broiler 58 
flocks and in humans. It provided a basis for comparative epidemiological and molecular 59 
studies for Hungary, keeping in mind that about 90 % of poultry meat consumed is produced 60 
in this country. Broiler strains (n=91) were provided by the Food and Feed Safety Directorate 61 
of the National Food Chain Safety Office (NEBIH), as part of the national Salmonella 62 
monitoring program, representing overwhelmingly the two major broiler breeds Ross 308 and 63 
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Cobb 500. Human strains of S. Infantis (n=95) were provided by the National Center for 64 
Epidemiology, representing sporadic clinical cases. Strains were stored at -80°C in LB (Luria-65 
Bertani) broth containing 10% glycerol. 66 
Antimicrobial susceptibility testing of S. Infantis strains was performed by disc 67 
diffusion against the listed antimicrobial compounds: ampicillin (Amp), cefotaxime(Ctx), 68 
chloramphenicol (Chl), ciprofloxacin (Cip), kanamycin (Kan), nalidixic acid (Nal), 69 
sulfonamide compounds (Sul), tetracycline (Tet) and trimethoprim (Tmp). Results were 70 
interpreted according to Clinical and Laboratory Standard Institute (CLSI) guidelines and 71 
interpretive standards (CLSI, 2013). S. Infantis isolates with intermediate zone diameter 72 
values to respective antimicrobials were considered susceptible. E. coli ATTC 25922 was 73 
used as a reference strain. 74 
2.2. Molecular characterization: pulsed-field gel electrophoresis, plasmid profiling and 75 
antimicrobial resistance genotyping 76 
A reduced number of broiler (n=31) and human (n=47) strains of S. Infantis were 77 
selected for molecular analysis (Table S1). Selection of the strains was based on their 78 
antimicrobial resistance phenotype to represent the diversity of the existing resistance 79 
patterns. As a reference, two sequenced strains of broiler origin, SI69/94 and SI54/04 were 80 
also included (Olasz et al., 2015). They represented the pre-emergent plasmid-free 81 
pansensitive isolates from the 1990s and the emerging MDR strains from the 2000s carrying 82 
the plasmid pSI54/04 respectively (Nógrády et al., 2007; Nógrády et al., 2008; Olasz et al., 83 
2015). 84 
PFGE analysis was carried out according to the CDC PulseNet standardized Salmonella 85 
protocol using Salmonella Braenderup H9812 as a molecular standard. PFGE-generated DNA 86 
profiles were entered into the Fingerprinting II Software (Bio-Rad Laboratories, Ventura, CA, 87 
USA). Cluster analysis was performed by the unweighted pair-group method (UPGMA) with 88 
arithmetic means. DNA sequence relatedness was calculated on the basis of the Dice’s 89 
coefficient. A 1.0% position tolerance and 1.5% optimization setting were applied. 90 
Plasmid preparation was carried out using the alkaline lysis method of Kado and Liu 91 
(1981), and plasmids were separated in 0.75% agarose gel in a vertical system. The 92 
approximate sizes of plasmids were estimated by comparing them with the reference plasmids 93 
of E. coli V517 (2.0–53.7 kb) and E. coli MD112 (168 kb) using the Quantity One software 94 
(Bio-Rad Laboratories). 95 
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Resistance gene patterns of the above selected strains were identified by AMR05 PCR-96 
microarray (http://alere-technologies.com/en/products/lab-solutions/amr-ve-genotyping.html), 97 
designed to detect among others several plasmidic genes conferring resistance to 98 
aminoglycosides, β-lactams (including extended spectrum β-lactams), quinolones and 99 
tetracyclines, as well as genes associated to class 1 and class 2 integrons (Batchelor et al., 100 
2008). Array spots were read with ArrayTube Reader ATR03 and the signals were detected 101 
and analyzed using IconoClust 2 software, with the positive threshold values set at ≥ 0.4. 102 
2.3. Sequence analysis of specific regions and PCR-typing of plasmid pSI54/04 103 
The deposited genome contigs of the emerging strain SI54/04 (Olasz et al., 2015) were 104 
used for the extraction of specific regions of plasmid pSI54/04 with functions in antimicrobial 105 
resistance, virulence, plasmid maintenance and transfer. As a reference for the assembly of 106 
these plasmidic regions, the corresponding contigs (ASRF01000099 - ASRF01000108) of the 107 
published megaplasmid pESI from an Israeli MDR strain of human S. Infantis were used 108 
(Aviv et al., 2014). Bioinformatic analysis was performed by Geneious 9.0.5 software 109 
package (Biomatters Ltd), for pairwise alignment the inbuilt application Geneious Alignment 110 
was used under default settings. 111 
In order to identify pSI54/04 and its possible variants, we developed a PCR typing 112 
system with primers designed to identify marker genes from each specific regions of the 113 
prototype plasmid pSI54/04. Primers and the corresponding target genes are presented in 114 
Table 1. Primers were tested for specificity against the NCBI nucleotide database by using 115 
BLAST. Broiler and human strains of S. Infantis that carried a large plasmid of >168 kb were 116 
subjected to pSI54/04 typing by using the above PCR system. The emerging strain SI54/04 117 
and the plasmid-free pre-emergent strain SI69/94 were included as positive and negative 118 
controls. Simplex PCR reactions were performed in a final volume of 25 µl, containing 0.6 u 119 
of PCRBIO Taq DNA polymerase, 5 µl of 5× PCRBIO Reaction buffer, 400 nM of each 120 
primer (Sigma-Aldrich), and 2 µl of template DNA. Amplifications were performed in a BIO-121 
RAD iCycler PCR system, and reaction conditions were uniform for all set of primers: 94 °C 122 
for 3 min, 35× 94 °C for 30 s, 60 °C for 1 min, 72 °C for 30 s and a final extension at 72 °C 123 
for 10 min. Detection of genes tet(A), intI1 and sul1 considered as prime markers for 124 
pSI54/04, were performed by the above PCR-microarray (Batchelor et al., 2008). Plasmid 125 
incompatibility of pSI54/04 was determined by PCR-based replicon typing (PBRT) developed 126 
by Carattoli et al. (2005). 127 
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2.4. Conjugative transfer of plasmid pSI54/04 and S. Infantis strains used for pathogenicity 128 
testing and the setup of in vitro and in vivo experiments 129 
To model the scenario of a possible transfer of pSI54/04 into a plasmid-free strain, the 130 
plasmid pSI54/04 was conjugated from the wild type (wt) strain SI54/04 into SI69/94 wt. The 131 
donor strain SI54/04 was resistant to both nalidixic acid and rifampicin (Nal-Rif). As the 132 
recipient strain SI69/94 was also resistant to Rif, the plasmid pST76-C having a 133 
thermosensitive pSC101ts replication system and catA1 gene, was transiently introduced by 134 
electroporation. This plasmid confers chloramphenicol (Chl) resistance for the 135 
SI69/94:pST76-Chl transformants grown at 30°C, but can easily be eliminated at 42°C (Pósfai 136 
et al., 1997). The transfer of plasmid pSI54/04 into SI69/94:pST76-Chl transformants was 137 
performed by conjugation. Transconjugant colonies were selected on LB plates supplemented 138 
with TetStrChl, incubated overnight at 30°C. Plasmid pST76-C then was cured from four 139 
StrSpcTetChl transconjugants by spreading onto LB/StrSpcTet plates incubated overnight at 140 
42°C. Single colonies were tested for the loss of Chl resistance marker and one resulting 141 
SI69/94:pSI54/04 transconjugant (StrSpcTet), was designated as HP1834 and selected for 142 
subsequent in vitro and in vivo pathogenicity studies using the emerging strain SI54/04 143 
carrying pSI54/04 and the pre-emergent plasmid-free strain SI69/94 as controls. For testing in 144 
vitro and in vivo pathogenicity, chicken embryo fibroblasts and day old chicks were infected 145 
with the above three strains markered for these purposes with nalidixic acid (Nal) resistance. 146 
2.5. Infection of chicken embryo fibroblasts 147 
Chicken embryo fibroblast (CEF) cell cultures were purchased from the Virology 148 
Laboratory, Veterinary Diagnostic Directorate of the National Food Chain Safety Office of 149 
Hungary, where freshly prepared cultures of CEFs are routinely used for virus isolation. CEFs 150 
were prepared from 12-day old chicken embryos of the Leghorn breed and maintained in 151 
MEM (Sigma-Aldrich) with 5% fetal calf serum (FCS) until infection. Handling of chicken 152 
embryos was performed in accordance with the relevant Hungarian legislation (Animal 153 
Protection and Welfare Act No. 103/2002). 154 
The day before infection, CEFs were seeded into 36 mm Petri dishes (Nunc) and grown 155 
for 18 hours at 37°C under 5% CO2. The invasiveness of S. Infantis strains in CEFs was 156 
tested as described by Barrow et al. (1989). Briefly, on the second day of growth, semi-157 
confluent cell cultures were washed 3× with HBSS (Sigma-Aldrich) and MEM was replaced 158 
with DMEM (Sigma-Aldrich) with 5% fetal calf serum and 1% D-mannose. CEFs were 159 
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infected for 2 h at 37°C and 5% CO2 with overnight bacterial cultures at a multiplicity of 160 
infection (MOI) equal to 10. After the incubation CEFs were washed 3× with HBSS and 161 
incubated for 1.5 h at 37 °C and 5% CO2 in MEM (Sigma-Aldrich) containing kanamycin 162 
250 µg/ml to eliminate extracellular bacteria. Finally, CEFs were digested with 0.025% 163 
trypsin (Sigma-Aldrich) and 1% Tween 20 (Sigma-Aldrich) in 0.01M NaH2PO4 (pH: 8) for 164 
30 min at 37 °C. Intracellular S. Infantis counts were determined by plating 10× dilutions on 165 
BTB plates. Infection with each of the strains was performed in two different experiments, 166 
with two replicates each. 167 
2.6. Infection of day old broiler chicks with S. Infantis 168 
For testing in vivo pathogenicity, 6 newly hatched broiler chickens (SPF, Ross308) per 169 
group were orally inoculated with 0.5 ml of the above three Nal resistant strains of S. Infantis. 170 
The infectious dose was ~107 CFU/animal and the infected chickens were killed humanely at 171 
5 days post infection. The control group consisted of 6 non-infected chickens killed on day 4 172 
of life, when the Salmonella-free status of the control group was also confirmed (ISO 6579). 173 
During sample processing, the cecal content and the spleen as well as 0.2g of the liver 174 
were removed aseptically from each bird. Cecal content was re-suspended in Rappaport 175 
Vassiliadis (RV) enrichment broth (1:10) containing nalidixic acid (50 µg/ml). From these 176 
suspensions, 10× dilutions were made from which 10 µl aliquots were plated onto nalidixic 177 
acid-selective BTB agar plates in order to determine the Salmonella colonization in the cecum 178 
(CFU/g). Liver and spleen samples were homogenized by using a STOMACHER 80 (Seward, 179 
Labsystem, UK) tissue homogenizer, in RV (1:50) supplemented with nalidix acid, and were 180 
further processed similar to the cecal samples in order to determine the organ invasion 181 
(CFU/g of Salmonella in the parenchymal organs). In vivo pathogenicity was tested in two 182 
independent experiments. The specific experiments were approved by the Food Chain Safety 183 
and Animal Health Directorate of the Pest County Government Office, Budapest (No. IV-I-184 
001/229-4/2012). 185 
2.7. Statistical analysis 186 
Statistical analysis concerning the prevalence of antimicrobial resistance phenotypes 187 
between 2011 and 2013, was performed by using the built-in regression analysis tool of the 188 
Analysis ToolPak for Excel. Determination coefficient (r2) values higher than 0.7 were 189 
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considered as indicating strong relation between the year of isolation and prevalence. 190 
Resistance patterns present in less than 5% of the strains were not included in the analysis. 191 
Statistical analysis of the pathogenic potential was performed by the Student’s t-test. 192 
Analysis aimed to detect differences in CEF invasion and cecal colonization abilities of the S. 193 
Infantis strains tested. Significant differences were considered at p<0.05. 194 
3. Results 195 
3.1. Multiresistance phenotype of Nal-Sul-Tet is predominant in recent isolates of S. Infantis 196 
Antimicrobial susceptibility testing of the 186 epidemiologically unrelated strains of S. 197 
Infantis from broilers and humans showed that 69 (75.8%) broiler and 57 (60.0%) human 198 
strains were resistant against multiple antimicrobial compounds representing at least three 199 
different antimicrobial classes. 200 
In general a large diversity of antimicrobial resistance patterns were observed for the 201 
tested strains of S. Infantis, but only four of these patterns reached a mean prevalence of >5% 202 
with nalidixic acid resistance in common (Fig. 1). The MDR pattern of nalidixic acid-203 
sulfonamide-tetracycline (Nal-Sul-Tet) was predominant both in broiler and in human 204 
collections with a mean prevalence of 69.3% and 50.8% respectively in the three years period. 205 
In the prevalence of the above dominant resistance pattern an increasing trend was observed 206 
between 2011 and 2013, ranging from 64.5% to 71.9% among broiler isolates (r2=0.80) and 207 
from 35.7% to 65.6% among isolates from humans (r2=0.99) (Fig. 1). 208 
The closely related resistance pattern of Nal-Sul, however was decreasing overtime 209 
particularly in humans (r2=0.93). In contrast to this, the prevalence of nalidixic acid resistance 210 
showed differing tendency between 2011-2013, and was increasing in broilers (from 6.5% to 211 
18.8%) but decreasing in humans (from 21.4% to 9.4%) (r2=0.80-0.97). Trimethoprim 212 
resistance (Tmp) was detected only in S. Infantis from broilers, in association with the 213 
multiresistance pattern Nal-Sul-Tet (12.9%). None of the broiler strains but 23.6% of the 214 
human strains were susceptible to all antimicrobials tested (Fig. 1). 215 
3.2. Molecular epidemiology of the plasmid pSI54/04 of emerging S. Infantis 216 
PFGE analysis of selected strains (n=78) of broiler and human origin revealed a 217 
diversity of clonal lineages, but three clones (B2, B1 and A1, in decreasing order) were 218 
regarded as major clones. The rest of them were represented by one isolate each. Strains from 219 
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clones B2 and B1 demonstrated the most prevalent MDR phenotype of Nal-Sul-Tet (Fig. S1, 220 
Table S2). A 54.8% of the broiler and 61.7% of the human strains were grouped into the 221 
PFGE clone B2 (17 and 29 strains respectively). Clone B1 was also common in broilers and 222 
humans (22.6% and 12.8%, with 7 and 6 strains) while clone A1 comprising the pansensitive 223 
isolates (susceptible to all antimicrobials tested) was identified in the human group only 224 
(12.8%, with 6 strains). There were further 12 minor clones identified, with one isolate each 225 
(Fig. S1, Table S2). Resistance to ampicillin was associated with a number of MDR 226 
phenotypes, and related strains were grouped into multiple clones (Table S2). Plasmid profile 227 
analysis resulted in the identification of large plasmids in 68 (32 broiler and 36 human) out of 228 
the 78 strains, indicating that these 68 strains may carry the ~277 kb plasmid pSI54/04 or its 229 
variants. This was confirmed and extended by PCR typing using the primers designed to 230 
identify representative genes from each specific region of pSI54/04. 231 
PCR typing detected the genes tet(A) (tetracycline resistance), merA (mercury 232 
resistance), intI1-aadA1-sul1 (class 1 integron), tehA (tellurit resistance) as appropriate 233 
marker genes for the antimicrobial- and heavy metal resistance regions of the prototype 234 
plasmid pSI54/04. Furthermore the genes irp1-fyuA (yersiniabactin), htrE-faeI-pefC (fimbrial 235 
proteins) were assigned as markers representing major virulence regions of this MDR 236 
plasmid. All these marker genes of pSI54/04 were shown by PCR to be present in the 237 
pSI54/04 transconjugant of the pre-emergent strain SI69/94 (designated as HP1834) but none 238 
of them, were present in the strain SI69/94. Same PCR typing results were obtained on the 239 
pSI54/04 transconjugant of E. coli K12 strain J5-3 (results not shown).  240 
From the 68 strains of S. Infantis subjected for pSI54/04-typing, the co-existence of the 241 
above resistance and virulence marker genes of pSI54/04 prototype plasmid was identified in 242 
a total of 54 strains (23 of 32 from broilers and 31 of 36 from humans). The pSI54/04 243 
prototype was mostly related to PFGE clone B2, and was associated with the predominant 244 
MDR phenotype Nal-Sul-Tet (Table 2, Fig. S1). We found that the specific virulence pattern 245 
of pSI54/04 was stable in all strains tested, but the resistance regions were more variable. 246 
Deletion of consecutive genes tet(A)-merA-intI1-aadA1-sul1 (variant 1) were detected in 247 
some broiler and human strains belonging mostly to clone B1. The rest of the variants 248 
occurred in some individual isolates and were characterized by the deletion of tet(A), intI1 or 249 
aadA1 genes. In case of multiplasmidic strains, the plasmid pSI54/04 was associated with 250 
plasmids carrying blaTEM-1 and qnrS genes conferring resistance to ampicillin and 251 
ciprofloxacin (Table 2). In one of the pSI54/04 negative strains representing clone A5 a large 252 
MDR plasmid of ~180 kb was identified, mediating resistance to Amp-Chl-Kan-Sul-Tet-Tmp 253 
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associated with intI1, sul1, aadA4, catA1, strB, sul2, tet(B), blaTEM-1 resistance genes (Table 254 
S2). 255 
Concerning the above functional regions and genes assigned for PCR typing of plasmid 256 
pSI54/04, we found in 89.4-100% sequence similarity between the Hungarian broiler MDR 257 
plasmid pSI54/04 and the Israeli human megaplasmid pESI of S. Infantis. The PCR-based 258 
replicon typing indicated that plasmid pSI54/04 belongs to the incompatibility group IncP. 259 
3.3.pSI54/04 did not increase pathogenic potential of S. Infantis in chicken fibroblasts and in 260 
day old chicks 261 
For testing pathogenic potential of pSI54/04, the two wild type strains, the plasmidic 262 
SI54/04 and the plasmid-free SI69/94 were compared with the plasmidic transconjugant of 263 
SI69/94 designated as HP1834 in terms of CEF invasion and cecal colonization in day old 264 
chicks. In vitro infection of CEFs resulted in a significantly (p <0.04) reduced invasion for 265 
both plasmidic strains SI54/04 and HP1834 (4.08 and 4.84 log10 CFU/ml) in comparison with 266 
the plasmid-free strain SI69/94 (4.98 log10 CFU/ml). In orally infected day old broiler chicks 267 
these three S. Infantis strains were colonizing the intestine in high numbers (7.22-7.86 log10 268 
CFU/g) without any significant differences but with somewhat reduced colonization by the 269 
plasmidic strains SI54/04 and HP1834 in comparison with the plasmid-free strain SI69/94 270 
(Fig. 2). None of the three strains proved to be invasive for parenchymal organs.  271 
4. Discussion 272 
According to the Commission Regulation (EC) No 1003/2005, S. Infantis is part of the 273 
community target for the reduction of the prevalence of certain Salmonella serovars in 274 
breeding flocks of Gallus gallus as one of the five most frequent Salmonella serovars in 275 
human salmonellosis. The prevalence of the most critical serovars S. Enteritidis and S. 276 
Typhimurium have been essentially reduced due to the effective prevention systems aimed 277 
primarily to these two serovars. Simultaneously however, S. Infantis became widespread in 278 
the broiler flocks of several European countries (EFSA and ECDC, 2015), and outside Europe 279 
(Asai et al., 2006; Shahada et al., 2006; Gal-Mor et al., 2010). The increased prevalence of S. 280 
Infantis among broilers could partly be a consequence of decreasing prevalence of S. 281 
Enteritidis due to reduction of intestinal inflammatory responses and/or changes in chicken 282 
microbiome potentially favourable for colonization by S. Infantis (Videnska et al., 2013; Mon 283 
et al., 2015). 284 
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However, in most countries there have been a switch in the epidemiology of S. Infantis 285 
strains around the late 1990s early 2000s associated with the increased incidence of 286 
multiresistant (MDR) strains and clonal lineages. In Hungary, results of Nógrády et al. (2007; 287 
2008) reported the emergence of the multiresistant PFGE cluster B of S. Infantis in human 288 
and broiler populations, characterized by a large (>168 kb) conjugative MDR plasmid 289 
carrying class 1 integron and tet(A) gene. This was followed by very similar reports from 290 
Israel (Gal-Mor et al. 2010), Japan (Shahada et al., 2008; 2010) and from several EU 291 
countries with additional appearance and dissemination of β-lactam-resistant isolates 292 
(Cloeckaert et al., 2007; Dionisi et al., 2011; Nógrády et al., 2012). Although these reports 293 
were indicating the role of large MDR plasmids in the emergence and spread, the molecular 294 
characterization of such plasmids encoding putative antimicrobial resistance, virulence and/or 295 
survival functions of the S. Infantis strains was lacking until recently. Such determinants of 296 
the megaplasmid pESI characterizing emergent MDR strains of S. Infantis of human origin 297 
have been reported from Israel (Aviv et al., 2014). 298 
Due to the high prevalence of S. Infantis in broiler carcasses and in broiler flocks in 299 
Hungary (EFSA, 2007; 2010), we have been focusing on epidemiologic markers of S. Infantis 300 
possibly related to this increase of multiresistance. Therefore we aimed to provide molecular 301 
characterization of plasmid pSI54/04 endemic in S. Infantis from broilers in Hungary, and 302 
distribution of associated antimicrobial resistance and virulence determinants within the 303 
endemic clones of Hungarian isolates of S. Infantis of broiler and human origin. In order to 304 
understand the background for the exceptionally high prevalence of S. Infantis in broiler 305 
flocks of Hungary, we also wanted to explore the pathogenic significance of this large 306 
conjugative MDR plasmid. 307 
Results on molecular typing of pSI54/04 typing based on the selected marker genes for 308 
resistance and virulence indicated that the pSI54/04 prototype plasmid was mostly related to 309 
PFGE clones B2 and B1 and was associated with the predominant MDR phenotype Nal-Sul-310 
Tet. The deletion of consecutive genes tet(A)-merA-intI1-aadA1-sul1 (variant 1) were 311 
detected in some broiler and human strains belonging mostly to clone B1. In case of three 312 
multiplasmidic strains representing clone B1 and B2, the plasmid pSI54/04 was associated 313 
with smaller plasmids (~45 kb) carrying blaTEM-1 and/or qnrS genes indicating potentially new 314 
emerging PFGE subclones. However these seemed to be different from those described by 315 
Kehrenberg et al. (2006), Dionisi et al. (2011) or Kameyama et al. (2012) for S. Infantis of 316 
broiler origin in Germany, Italy and Japan respectively. 317 
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Concerning specific functional regions and genes assigned as resistance and virulence 318 
markers, plasmid pSI54/04 of Hungarian broiler origin has shown a high sequence similarity 319 
with the Israeli megaplasmid pESI of human origin (Aviv et al., 2014). PBRT indicated IncP 320 
incompatibility for pSI54/04, although it seems that the functional incompatibility group of 321 
certain MDR plasmids of S. Infantis is difficult to determine (Aviv et al., 2014; Dionisi et al., 322 
2016). 323 
The source of human infections by S. Infantis has been mainly related to poultry meat. 324 
The carcass prevalence of S. Infantis was 85% in Hungary (EFSA, 2010) and it was around 325 
50% in poultry processing plants in Israel (Gal-Mor et al., 2010). In spite of this, the reported 326 
incidence of human infections caused by S. Infantis in Hungary and Israel were quite 327 
different: 4.4 cases of S. Infantis infection/100,000 in Hungary in contrast to 14.7/100,000 in 328 
Israel, representing 8.6% and 34% of Salmonella isolates respectively (Anonymous, 2016; 329 
Gal-Mor et al., 2010). One explanation for this discrepancy could theoretically be a higher 330 
pathogenicity of the S. Infantis strains prevalent in Israel (Aviv et al., 2014), but several other 331 
factors such as differences in the infectious disease surveillance systems, as well as 332 
differences in climatic conditions could also play their role. 333 
Testing pathogenicity of the emerging plasmidic S. Infantis strain SI54/04 of broiler 334 
origin in comparison with a pre-emergent strain SI69/94 and its pSI54/04 transconjugant on 335 
CEFs and on orally infected day old chicks, showed reduced in vitro invasion and in vivo 336 
colonization by the pSI54/04 transconjugant strain. This reduction of pathogenic potential as 337 
compared to the plasmidless pre-emerging strain SI69/94 indicated that the pathogenicity of 338 
S. Infantis could not be influenced by the plasmid pSI54/04 in chicken host, in contrast to the 339 
results about pathogenic significance of pESI in a mouse model (Aviv et al. 2014). One 340 
reason for a possible differing pathogenic potential of the Hungarian and the Israeli strains 341 
could also be in their differing host adaptation (Alvarez-Ordóñez et al., 2015; Langridge et al., 342 
2015). In case of S. Infantis, the adaptation to the chicken host could have resulted in a more 343 
attenuated host-pathogen interaction in chicken models. The degrees of pathogenicity for 344 
different hosts (i.e. for human, mouse or chicken) may also differ between clusters of S. 345 
Infantis as it has been reported by Yokoyama et al. (2015). 346 
As the Hungarian strain SI54/04 of S. Infantis used for pathogenicity studies have been 347 
of broiler origin, the choice of using primary CEF cells and day old broiler chick models for 348 
in vitro and in vivo pathogenicity testing of our S. Infantis strains was appropriate. These 349 
systems have already been useful in our earlier studies on poultry strains of Salmonella 350 
Enteritidis as well (Imre et al., 2015; Szmolka et al., 2015). On the other hand, it could also be 351 
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hypothesized that the predominant S. Infantis strains in Israel could have more efficiently 352 
utilized the specific virulence determinants of the plasmid pESI in a mouse model and in 353 
immortalized cell lines thereby enhancing pathogenicity and stress tolerance of the recipient 354 
strains (Aviv et al., 2014). However, elucidation of the role of these factors would need a 355 
systematic comparative study in the same in vitro and in vivo models, using the same parental 356 
S. Infantis strains and their transconjugants containing pSI54/04 and pESI respectively, 357 
produced by the same methods and verified for both plasmids by detailed molecular analysis. 358 
Such detailed comparative studies on these two plasmids and their carrier S. Infantis strains 359 
were outside the scope of our molecular epidemiology approach. 360 
5. Conclusion 361 
These results of molecular epidemiologic studies on the plasmid pSI54/04 are extending 362 
the earlier reports from Hungary, Israel and from Japan on the significance of large MDR 363 
plasmids in dissemination and persistence of emerging S. Infantis clones. Our findings 364 
indicate that the plasmid pSI54/04 contributes to the multiresistance of endemic clones of S. 365 
Infantis in Hungary. Concerning specific regions with functions in antimicrobial resistance, 366 
virulence, plasmid maintenance and transfer plasmid pSI54/04 shares a high sequence 367 
similarity with the plasmid pESI endemic in S. Infantis from humans in Israel, thus, it could 368 
also be referred to as a pESI-like plasmid. The transfer of pSI54/04 to a pre-emergent S. 369 
Infantis of broiler origin did not increase the pathogenic potential of this strain in the in vitro 370 
and in vivo chicken models. Thus, plasmid pSI54/04 assisted dissemination of S. Infantis by 371 
antimicrobial resistance determinants rather than by the virulence genes. Our studies also 372 
highlighted that the emergence of plasmids blaTEM-1 and qnrS mediating β-lactam- and 373 
fluoroquinolone resistance, that have already been described in other countries, may become 374 
more prevalent in the Hungarian broiler and human populations in the future. 375 
Acknowledgements 376 
We would like to thank Emília Szállás for providing chicken embryo fibroblast cell 377 
cultures for infection experiments and Orsolya Saller for the technical assistance. Thanks are 378 
due also to Dr. Alessandra Carattoli for providing the positive control strains for PBRT as 379 
well as for Dr. Levente Emődy, Dr. Ariel Imre and Dr. Noémi Nógrády for their advise and 380 
consent during these studies. This study was supported by the National Research Fund OTKA 381 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 14 
(Contract no. 101546). A. Szmolka is holder of a Bolyai János Stipend from the Hungarian 382 
Academy of Sciences. 383 
Conflict of interest statement 384 
The authors have no financial or commercial conflicts of interest to declare. 385 
References 386 
Alvarez-Ordóñez, A., Broussolle, V., Colin, P., Nguyen-The, C., Prieto, M., 2015. The 387 
adaptive response of bacterial food-borne pathogens in the environment, host and food: 388 
Implications for food safety. Int. J. Food Microbiol. 213, 99–109. 389 
Anonymous. National Center for Epidemiology, 2016. Epidemiology Report of Hungary for 390 
2015 (in Hungarian). Epinfo. 23(27), 309-310. 391 
Asai, T., Itagaki, M., Shiroki, Y., Yamada, M., Tokoro, M., Kojima, A., Ishihara, K., Esaki, 392 
H., Tamura, Y., Takahashi, T., 2006. Antimicrobial resistance types and genes in 393 
Salmonella enterica infantis isolates from retail raw chicken meat and broiler chickens on 394 
farms. J. Food Prot. 69, 214–216. 395 
Aviv, G., Tsyba, K., Steck, N., Salmon-Divon, M., Cornelius, A., Rahav, G., Grassl, G.A., 396 
Gal-Mor, O., 2014. A unique megaplasmid contributes to stress tolerance and 397 
pathogenicity of an emergent Salmonella enterica serovar Infantis strain. Environ. 398 
Microbiol. 16, 977–994. 399 
Barrow, P.A., Lovell, M.A., 1989. Invasion of Vero cells by Salmonella species. J. Med. 400 
Microbiol. 28, 59–67. 401 
Batchelor, M., Hopkins, K., Liebana, E., Slickers, P., Ehricht, R., Mafura, M., Aarestrup, F., 402 
Mevius, D., Clifton-Hadley, F., Woodward, M., Davies, R., Threlfall, Anjum, M., 2008. 403 
Development of a miniaturised microarray-based assay for the rapid identification of 404 
antimicrobial resistance genes in Gram-negative bacteria. International Journal of 405 
Antimicrobial agents 31, 440–451. 406 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 15 
Carattoli, A., Bertini, A., Villa, L., Falbo, V., Hopkins, K.L., Threlfall, E.J., 2005. 407 
Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63, 219–408 
228. 409 
CLSI, Clinical and Laboratory Standards Institute, 2013. Performance standards for 410 
antimicrobial susceptibility testing. Twenty-Third Informational Supplement. CLSI 411 
Wayne, PA, USA(M100-S23). 412 
Commission Regulation (EC) No 1003/2005 of 30 June 2005 implementing Regulation (EC) 413 
No 2160/2003 as regards a Community target for the reduction of the prevalence of certain 414 
salmonella serotypes in breeding flocks of Gallus gallus and amending Regulation (EC) 415 
No 2160/2003. 416 
Cloeckaert, A., Praud, K., Doublet, B., Bertini, A., Carattoli, A., Butaye, P., Imberechts, H., 417 
Bertrand, S., Collard, J.-M.M., Arlet, G., Weill, F.-X.X., 2007. Dissemination of an 418 
extended-spectrum-beta-lactamase blaTEM-52 gene-carrying IncI1 plasmid in various 419 
Salmonella enterica serovars isolated from poultry and humans in Belgium and France 420 
between 2001 and 2005. Antimicrob. Agents Chemother. 51, 1872–1875. 421 
Dionisi, A.M., Lucarelli, C., Benedetti, I., Owczarek, S., Luzzi, I., 2011. Molecular 422 
characterisation of multidrug-resistant Salmonella enterica serotype Infantis from humans, 423 
animals and the environment in Italy. Int. J. Antimicrob. Agents 38, 384–389. 424 
Dionisi, A.M., Owczarek, S., Benedetti, I., Luzzi, I., García-Fernández, A., 2016. Extended-425 
spectrum β-lactamase-producing Salmonella enterica serovar Infantis from humans in 426 
Italy. Int. J. Antimicrob. Agents 48, 345–346. 427 
European Food Safety Authority (EFSA), 2007. Report of the Task Force on Zoonoses Data 428 
Collection on the Analysis of the baseline survey on the prevalence of Salmonella in 429 
broiler flocks of Gallus gallus, Part A. European Food Safety Authority Journal 98, 1–85. 430 
European Food Safety Authority, 2010. The Community Summary Report on Trends and 431 
Sources of Zoonoses, Zoonotic Agents and food-borne outbreaks in the European Union in 432 
2008. European Food Safety Authority Journal 8, 1496. 433 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 16 
European Food Safety Authority (EFSA) and European Centre for Disease Prevention and 434 
Control (ECDC), 2015. The European Union summary report on trends and sources of 435 
zoonoses, zoonotic agents and food-borne outbreaks in 2014, EFSA Journal 13, 4329. 436 
Gal-Mor, O., Valinsky, L., Weinberger, M., Guy, S., Jaffe, J., Schorr, Y.I., Raisfeld, A., 437 
Agmon, V., Nissan, I., 2010. Multidrug-resistant Salmonella enterica serovar Infantis, 438 
Israel. Emerging Infect. Dis. 16, 1754–1757. 439 
Imre, A., Szmolka, A., Olasz, F., Nagy, B., 2015. Vaccine potential of a nonflagellated, 440 
virulence-plasmid-cured (fliD-, pSEV∆) mutant of Salmonella Enteritidis for chickens. 441 
Acta Vet. Hung. 63, 285–302. 442 
Kado, C.I., Liu, S.T., 1981. Rapid procedure for detection and isolation of large and small 443 
plasmids. J. Bacteriol. 145, 1365–1373. 444 
Kameyama, M., Chuma, T., Yokoi, T., Yabata, J., Tominaga, K., Miyasako, D., Iwata, H., 445 
Okamoto, K., 2012. Emergence of Salmonella enterica Serovar Infantis Harboring IncI1 446 
Plasmid with bla CTX-M-14 in a Broiler Farm in Japan. J. Vet. Med. Sci. 74, 1213–1216. 447 
Kehrenberg, C., Friederichs, S., Jong, A. de, Michael, G.B., Schwarz, S., 2006. Identification 448 
of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar 449 
Infantis. J. Antimicrob. Chemother. 58, 18–22. 450 
Langridge, G.C., Fookes, M., Connor, T.R., Feltwell, T., Feasey, N., Parsons, B.N., Seth-451 
Smith, H.M., Barquist, L., Stedman, A., Humphrey, T., Wigley, P., Peters, S.E., Maskell, 452 
D.J., Corander, J., Chabalgoity, J.A., Barrow, P., Parkhill, J., Dougan, G., Thomson, N.R., 453 
2015. Patterns of genome evolution that have accompanied host adaptation in Salmonella. 454 
Proc. Natl. Acad. Sci. U.S.A. 112, 863–868. 455 
Mon, K.K., Saelao, P., Halstead, M.M., Chanthavixay, G., Chang, H.-C.C., Garas, L., Maga, 456 
E.A., Zhou, H., 2015. Salmonella enterica Serovars Enteritidis Infection Alters the 457 
Indigenous Microbiota Diversity in Young Layer Chicks. Front Vet Sci 2, 61. 458 
Murakami, K., Ishihara, T., Horikawa, K., Oda, T., 2007. Features of Salmonella serovars 459 
among food handlers in Kyushu, Japan. New Microbiol. 30, 155–159. 460 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 17 
Nógrády, N., Tóth, A., Kostyák, A., Pászti, J., Nagy, B., 2007. Emergence of multidrug-461 
resistant clones of Salmonella Infantis in broiler chickens and humans in Hungary. J. 462 
Antimicrob. Chemother. 60, 645–648. 463 
Nógrády, Kardos, Bistyák, Turcsányi, Mészáros, Galántai, Z., Juhász, Á., Samu, 464 
Kaszanyitzky, J.É., Pászti, Kiss, 2008. Prevalence and characterization of Salmonella 465 
infantis isolates originating from different points of the broiler chicken–human food chain 466 
in Hungary. Int J Food Microbiol 127, 162–167. 467 
Nógrády, N., Király, M., Davies, R., Nagy, B., 2012. Multidrug resistant clones of Salmonella 468 
Infantis of broiler origin in Europe. Int. J. Food Microbiol. 157, 108–112. 469 
Olasz, F., Nagy, T., Szabó, M., Kiss, J., Szmolka, A., Barta, E., Tonder, A. van, Thomson, N., 470 
Barrow, P., Nagy, B., 2015. Genome Sequences of Three Salmonella enterica subsp. 471 
enterica Serovar Infantis strains from Healthy Broiler Chicks in Hungary and in the United 472 
Kingdom. Genome Announc. 3, e01468-14. 473 
Pósfai, G., Koob, M.D., Kirkpatrick, H.A., Blattner, F.R., 1997. Versatile insertion plasmids 474 
for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the 475 
pathogenicity island LEE of the Escherichia coli O157:H7 genome. J. Bacteriol. 179, 476 
4426–4428. 477 
Schubert, S., Rakin, A., Karch, H., Carniel, E., Heesemann, J., 1998. Prevalence of the “high-478 
pathogenicity island” of Yersinia species among Escherichia coli strains that are 479 
pathogenic to humans. Infect. Immun. 66, 480–485. 480 
Shahada, F., Chuma, T., Tobata, T., Okamoto, K., Sueyoshi, M., Takase, K., 2006. Molecular 481 
epidemiology of antimicrobial resistance among Salmonella enterica serovar Infantis from 482 
poultry in Kagoshima, Japan. Int. J. Antimicrob. Agents 28, 302–307. 483 
Shahada, F., Chuma, T., Okamoto, K., Sueyoshi, M., 2008. Temporal distribution and genetic 484 
fingerprinting of Salmonella in broiler flocks from southern Japan. Poult. Sci. 87, 968–972. 485 
Shahada, F., Chuma, T., Dahshan, H., Akiba, M., Sueyoshi, M., Okamoto, K., 2010. 486 
Detection and characterization of extended-spectrum beta-lactamase (TEM-52)-producing 487 
Salmonella serotype Infantis from broilers in Japan. Foodborne Pathog. Dis. 7, 515–521. 488 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 18 
Szmolka, A., Wiener, Z., Matulova, M.E., Varmuzova, K., Rychlik, I., 2015. Gene 489 
Expression Profiles of Chicken Embryo Fibroblasts in Response to Salmonella Enteritidis 490 
Infection. PLoS ONE 10, e0127708. 491 
Videnska, P., Faldynova, M., Juricova, H., Babak, V., Sisak, F., Havlickova, H., Rychlik, I., 492 
2013. Chicken faecal microbiota and disturbances induced by single or repeated therapy 493 
with tetracycline and streptomycin. BMC Vet. Res. 9, 30. 494 
Yokoyama, E., Ando, N., Ohta, T., Kanada, A., Shiwa, Y., Ishige, T., Murakami, K., Kikuchi, 495 
T., Murakami, S., 2015. A novel subpopulation of Salmonella enterica serovar Infantis 496 
strains isolated from broiler chicken organs other than the gastrointestinal tract. Vet. 497 
Microbiol. 175, 312–318. 498 
  499 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
 19 
Figure legends 500 
Fig. 1. Prevalence of associated antimicrobial resistance phenotypes of recently isolated S. 501 
Infantis of broiler and human origin. A total of 186 S. Infantis strains from the above sources, 502 
isolated between 2011-2013 were clustered according to the antimicrobial resistance patterns. 503 
Most frequent resistance phenotypes with a prevalence of >5% are presented within the 504 
frame. 505 
Fig. 2. In vitro and in vivo pathogenic potential of emerging plasmidic and the pre-emergent 506 
plasmid-free strains of S. Infantis. For testing pathogenic potential of pSI54/04, the two 507 
reference wild strains, the plasmidic SI54/04 and the plasmid-free SI69/94 were compared 508 
with the plasmidic transconjugant of SI69/94 (designated as HP1834) in terms of CEF 509 
invasion and cecal colonization in day old chicks. 510 
 511 
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Tables 
Table 1. Specific regions and marker genes of prototype plasmid pSI54/04 used as targets for PCR-based plasmid detection and typing. 
Gene Description pSI54/04 target region Forward primer sequence Reverse primer sequence 
Amplicon 
(bp) 
merA mercuric ion reductase antimicrobial resistance GATGTCTCCTACGCCAAGGG CCTATAGCTGGGTCTTCGCG  842 
tehA tellurit resistance protein tehA heavy metal resistance CAAGGAGCTGTGTGGTTTGC GTATTATCCCCTGGAGCCGC 642 
repA DNA replication protein plasmid maintenance CACTTTGTCCTTTCGCGGTG TAAGGTCTGGCTCGGGATCA 616 
irp1 iron aquisition yersiniabactin synthesis enzyme iron aquisition GAAACGCCACACTTCACCAC AGCACGTTGTCCATGCAGTA 581 
fyuA iron aquisition outermembrane yersiniabactin 
receptor (FyuA, Psn, pesticin receptor) 
iron aquisition TGGGAAATACACCACCGACG * CGCAGTAGGCACGATGTTGTA 541 
pefC plasmid encoded fimbriae adhesion CGGCATCATTCCCGAGTACA AGGCCGGGATTTATGTCAGC  587 
faeI K88 minor fimbrial subunit faeI precursor adhesion TGCAGGTCGTCATACAACCC AATCCCTGGGTCTGGAAGGT 365 
htrE outer membrane usher protein htrE precursor adhesion TTCCCGTCTCCTCTGCTGTA ACTGGCTGCCTACCGGTATA 414 
* Schubert et al., 1998 
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Table 2. Prototype plasmid pSI54/04 and its variants with differing gene patterns in antimicrobial- and heavy metal resistance regions. Gene 
pattern and the plasmidic environment of pSI54/04 and its variants are presented in relation with the PFGE clone. 
pSI54/04-like 
plasmids 
Resistance genes of pSI54/04 Virulence genes of pSI54/04 pSI54/04 
range (~ kb) 
Associated plasmidic 
resistance genes 
PFGE clone (n) Origin (n) 
pSI54/04 
prototype tet(A), merA, intI1, aadA1, sul1, tehA irp1, fyuA, htrE, faeI, pefC 
190-225 - B2(43), B1(4), B3, A1, L1, M1, N1, O1, P1 
broiler (23) 
human (31) 
225 blaTEM-1 B2 broiler (1) 
180 blaTEM-1, qnrS B1 human (1) 
variant 1 - tehA irp1, fyuA, htrE, faeI, pefC 175-200 - B2(2), B1(6), B10 broiler (6) 
human (3) 
variant 2 - merA, intI1, aadA1, sul1, tehA irp1, fyuA, htrE, faeI, pefC 225 - B1 broiler (1) 
variant 3 tet(A), merA, - aadA1, sul1, tehA irp1, fyuA, htrE, faeI, pefC 200 blaTEM-1 B1 human (1) 
Plasmids carrying the gene blaTEM-1 were ~45 kb large in size. 
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Supporting information legends 
Table S1. List of the 186 isolates of S. Infantis of broiler and human origin included in this 
study. Strains are grouped according to the resistance phenotype. Grey background indicates 
strains selected for further molecular characterization (n=78). 
Table S2. Antimicrobial resistance pheno- and genotype of S. Infantis of broiler and human 
origin in major and minor PFGE clones. Grey background indicates strains carrying pSI54/04 
plasmid or its variants. 
Fig. S1. Distribution of PFGE clones of S. Infantis of broiler and human origin. 
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Highlights 
to the this manuscript entitled ‘Molecular epidemiology of the endemic multiresistance 
plasmid pSI54/04 of Salmonella Infantis in broiler and human population in Hungary’ 
• plasmid pSI54/04 contributes to multiresistance in recent isolates of S. Infantis 
 
• pSI54/04 and plasmid pESI of S. Infantis in Israel share high sequence similarity 
 
• variants of pSI54/04 differ in antimicrobial- and heavy metal resistance regions 
 
• transfer of pSI54/04 did not increase pathogenic potential of S. Infantis  
 
